HS Code 30021300 — Immunological products, unmixed, not put up in measured doses
Chapter 30 (Pharmaceutical Products) · Heading 3002 (Blood, antisera, vaccines, toxins, microorganisms and similar products) · Last updated: May 2026 · Source: Indian Customs (DGFT) Records
HS Code 30021300 (Immunological products, unmixed, not put up in measured doses) is one of India's most significant pharmaceutical export classifications under Chapter 30 of the Harmonized System. With a total trade value of $22.3M across 1,664 shipments, this code covers 17 distinct pharmaceutical products exported by 65 Indian manufacturers to 69 countries. The leading product under this classification is Bevacizumab at $12.8M, followed by Rituximab and Ras.
The top importing markets include United States, Netherlands, Singapore. The top 5 products account for 89.2% of total trade under this code. Average transaction value is $13.4K. Leading exporters include M/S. NOVO NORDISK A/S and SANOFI-AVENTIS SINGAPORE PTE LTD. Data sourced from Indian Customs (DGFT) shipping bill records.
Products Exported Under HS Code 30021300
17 pharmaceutical products classified under this code, ranked by trade value
| Rank | Product | Trade Value | Transactions | Avg Price | Suppliers |
|---|---|---|---|---|---|
| #1 | Bevacizumab | $12.8M | 52 | $264.05 | 6 |
| #2 | Rituximab | $2.4M | 7 | $236.92 | 2 |
| #3 | Ras | $2.2M | 367 | $5774.34 | 10 |
| #4 |